- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
Patent holdings for IPC class A61K 38/33
Total number of patents in this class: 96
10-year publication summary
|
3
|
5
|
7
|
2
|
6
|
5
|
2
|
4
|
9
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
22 |
| Ipsen Pharma S.A.S. | 377 |
12 |
| Endevica bio, Inc. | 66 |
12 |
| NED Biosystems, Inc. | 11 |
3 |
| Trustees of Tufts College | 981 |
3 |
| Tufts Medical Center, Inc. | 236 |
3 |
| Aequus Biopharma, Inc. | 3 |
2 |
| Aimsco Limited | 7 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| Genomictree, Inc. | 51 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4780 |
2 |
| Serina Therapeutics, Inc. | 47 |
2 |
| University of Cincinnati | 931 |
2 |
| FGS Scientific Pty Ltd | 2 |
2 |
| Centre National de La Recherche Scientifique | 11055 |
1 |
| Centre hospitalier universitaire de Rouen | 61 |
1 |
| Charite - Universitatsmedizin Berlin | 385 |
1 |
| Galderma Research & Development | 351 |
1 |
| Medizinische Universitat Wien | 191 |
1 |
| Palatin Technologies, Inc. | 59 |
1 |
| Other owners | 19 |